This is orally bioavailable small molecule with significantly enhanced tumor cell kill by IR and topoisomerase I in vitro and in vivo173; in addition, it showed single‐agent activity and synergy in combination with PARP inhibitors in BRCA1/2‐mutated models.173. Here, BRCA1 is linked to neoplasm.